Fulcrum Therapeutics Newsroom

Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Fulcrum Therapeutics (FULC) and Immunic (IMUX)

TipRanksNov 19 02:26 ET

Oppenheimer Maintains Fulcrum Therapeutics(FULC.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsNov 14 08:35 ET

RBC Capital Maintains Fulcrum Therapeutics(FULC.US) With Hold Rating, Maintains Target Price $4

Moomoo NewsNov 14 07:31 ET

Fulcrum Therapeutics Analyst Ratings

BenzingaNov 14 06:53 ET

H.C. Wainwright Maintains Fulcrum Therapeutics(FULC.US) With Hold Rating, Maintains Target Price $4

Moomoo NewsNov 14 06:31 ET

A Quick Look at Today's Ratings for Fulcrum Therapeutics(FULC.US), With a Forecast Between $2 to $22

Moomoo NewsSep 13 09:00 ET

Hold Rating on Fulcrum Therapeutics Amid Phase 3 Drug Failure and Pivot to Sickle Cell Disease Candidate

TipRanksSep 13 06:20 ET

RBC Downgrades Fulcrum Therapeutics to Sector Perform From Outperform, Cuts Price Target to $4 From $15; Speculative Risk Kept

MT NewswiresSep 13 06:17 ET

Fulcrum Therapeutics Price Target Announced at $4.00/Share by Leerink Partners

Dow JonesSep 12 15:46 ET

Fulcrum Therapeutics Cut to Market Perform From Outperform by Leerink Partners

Dow JonesSep 12 15:46 ET

Fulcrum Therapeutics Analyst Ratings

BenzingaSep 12 11:19 ET

Stifel Downgrades Fulcrum Therapeutics(FULC.US) to Hold Rating, Maintains Target Price $22

Moomoo NewsSep 12 08:31 ET

Stifel Nicolaus Keeps Their Buy Rating on Fulcrum Therapeutics (FULC)

TipRanksSep 12 07:37 ET

Fulcrum Therapeutics Raised to Neutral From Underperform by B of A Securities

Dow JonesSep 9 07:53 ET

Fulcrum Therapeutics Analyst Ratings

BenzingaSep 9 07:42 ET

BofA Securities Upgrades Fulcrum Therapeutics(FULC.US) to Hold Rating, Announces Target Price $10

Moomoo NewsSep 9 06:31 ET

RBC Capital Maintains Fulcrum Therapeutics(FULC.US) With Buy Rating, Raises Target Price to $15

Moomoo NewsSep 3 08:31 ET

Stifel Maintains Fulcrum Therapeutics(FULC.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsAug 15 08:34 ET

Stifel Nicolaus Keeps Their Buy Rating on Fulcrum Therapeutics (FULC)

TipRanksAug 15 08:20 ET

Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Exact Sciences (EXAS) and Fulcrum Therapeutics (FULC)

TipRanksAug 5 02:27 ET